Patent · US Expired

Dosage forms

US6221394A · kind A · utility

13Cited by
1References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 5, 2000
Grant dateApr 24, 2001
Priority date
Expiry dateJan 5, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/2054
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical dosage form comprises, in one portion thereof, a substantially single (+)-enantiomer of a chiral drug other than verapamil and, in another, separate portion thereof, a substantially single (-)-enantiomer of the drug wherein, in use, the different enantiomers are released at different rates from the dosage form. The dosage form is useful for administration of chiral drugs where both enantiomers have a valid pharmacological input, and where a clinical benefit may be realised by controlling the release rates of those enantiomers. Examples of such drugs include, in particular, tramadol and warfarin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.